Clinical outcomes of targeted therapies in elderly patients aged ≥ 80 years with metastatic colorectal cancer

doi:10.12998/wjcc.v10.i28.10066

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 28

This Article

(142)

(163)

(0)

(7)

(1)

(3580)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Retrospective Study

World J Clin Cases. Oct 6, 2022; 10(28): 10066-10076
Published online Oct 6, 2022. doi: 10.12998/wjcc.v10.i28.10066

Table 3 Salvage chemotherapy

	Group with TA (n: 15)	Group without TA (n: 15)
2^ndline chemotherapy, %
Yes	4 (26.7)	8 (53.3)
No	11 (73.3)¹	7 (46.7)
2^nd line chemotherapy agents, %
FOLFOX	3 (75.0)	0
FOLFIRI	0	6 (75.0)
Capecitabine	1 (25.0)	2 (25.0)
No of chemotherapy line, %
1^st line	11* (73.3)	7 (46.7)
2^nd line	2 (13.3)	5 (31.3)
3^rd line	2 (13.3)	3 (20.0)

¹Two patients with targeted agent had chemotherapy holiday after first-line treatment. FOLFOX: Fluorouracil, leucovorin and oxaliplatin; FOLFIRI: Fluorouracil, leucovorin and irinotecan; TA: Targeted agent.

Full Size Table

Citation: Jang HR, Lee HY, Song SY, Lim KH. Clinical outcomes of targeted therapies in elderly patients aged ≥ 80 years with metastatic colorectal cancer. World J Clin Cases 2022; 10(28): 10066-10076
URL: https://www.wjgnet.com/2307-8960/full/v10/i28/10066.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i28.10066

Jang HR, Lee HY, Song SY, Lim KH. Clinical outcomes of targeted therapies in elderly patients aged ≥ 80 years with metastatic colorectal cancer. World J Clin Cases 2022; 10(28): 10066-10076 [PMID: 36246797 DOI: 10.12998/wjcc.v10.i28.10066]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.